Related Experiment Video
Updated: Mar 28, 2026
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
16.7K
Blastic plasmacytoid dendritic cell neoplasm: A single centre Indian experience
Paramasivam Sabitha1, Aastha Goel1, Santhosh Kumar1
1Department of Medical Oncology, Dr. B. R. Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, 110029, India.
Leukemia Research Reports
|March 27, 2026
Summary
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare cancer. Managing BPDCN presents significant challenges due to limited effective therapies and expertise, impacting patient prognosis.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy.
- Recognized as a distinct entity by the WHO in 2016, BPDCN often presents with skin lesions and involves bone marrow, lymph nodes, and the central nervous system.
- The disease affects all age groups and poses diagnostic and therapeutic challenges, contributing to a poor prognosis.
